DZ Bank’s Pfizer PFE Stock Holding History

DZ Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-316	Closed	-$10K	–	932
2017 Q2	$10K	Buy	+316	New	+$9.96K	﹤0.01%	895

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank's PFE Position: Q2 2026 in Review

DZ Bank reduced its Pfizer (PFE) stake by 7.1% in Q2 2026, selling an estimated $2.5M and leaving 1,245,945 shares worth $30M. The position accounts for 0.02% of the portfolio, ranked #226.

DZ Bank first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.43B in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DZ Bank held 1,245,945 shares of Pfizer worth $30M as of Q2 2026.
DZ Bank sold 95,526 Pfizer shares in Q2 2026, an estimated $2.5M.
Pfizer made up 0.02% of DZ Bank's portfolio in Q2 2026, its #226 holding.
DZ Bank first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
DZ Bank's Pfizer position peaked at $1.43B in Q4 2021.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.